Karin, M., et al. 2004. Nat. Rev. Drug Dis. 3, 17; Greten, F.R., and Karin, M. 2004. Cancer Lett. 206, 193; Jones, W.K., et al. 2003. Cardiovasc. Toxicol. 3
229; Richmond, A. 2002. Nat. Rev. Immunol
Prkcb P NP_001165776.1 n/d n/d y
584 Protein Kinase Cβ3 P2584 25023 Prkcb M NP_001165776.1 n/d n/d y
433 MAP1 M4278 25152 Map1a M NP_112257.1 n/d y y
310 GRK 2 G7670 25238 Adrbk1 M NP_036908.1 y n/d y
478
Prkcb P NP_001165776.1 n/d n/d y
584 Protein Kinase Cβ3 P2584 25023 Prkcb M NP_001165776.1 n/d n/d y
433 MAP1 M4278 25152 Map1a M NP_112257.1 n/d y y
310 GRK 2 G7670 25238 Adrbk1 M NP_036908.1 y n/d y
478
Prkcb P NP_001165776.1 n/d n/d y
584 Protein Kinase Cβ3 P2584 25023 Prkcb M NP_001165776.1 n/d n/d y
433 MAP1 M4278 25152 Map1a M NP_112257.1 n/d y y
310 GRK 2 G7670 25238 Adrbk1 M NP_036908.1 y n/d y
478
C-terminus, a.a. 2269-2541 TD77 H M Ch WB IP IC Pur M IgG1 100 µg MAB3264
Talin, N-terminus, a.a. 139-433 TA205 H M R Rb WB IP IH Pur M IgG1 100 µg MAB1676
Tensin
Monoclonal Antibody
Tensin
Kinase (MEK, MAPKK) M5795 P y y y
431 MAP2 (2a+2b) M2320 M n/d n/d y
432 Anti Cy3+Cy5 C0992 M NA NA NA
433 MAP1 M4278 M n/d y y
434 MAP1 (Light Chain) M6783 M n/d n/d y
435 MAP1b M4528 M y
M2320 25595, 17756, 4133 MAP2,Mtap2 NP_037198.1,NP_032658.2,NP_114035.2 M n/d n/d y
432 Anti Cy3+Cy5
433 MAP1 M4278 25152, 17754 Mtap1a NP_112257.1,NP_115769.1 M n/d y y
434 MAP1 (Light Chain) M6783 362245
25595, 17756, 4133 MAP2,Mtap2 NP_037198.1,NP_032658.2,NP_114035.2 M n/d n/d y
432 Anti Cy3+Cy5 C0992
433 MAP1 M4278 25152, 17754 Mtap1a NP_112257.1,NP_115769.1 M n/d y y
434 MAP1 (Light Chain) M6783 362245
40 % B in 35 min
Flow rate 3 µL/min
Sample Cytochrom C digest
Chromolith® CapRod®
www.emdmillipore.com/analytical-hplc
An
al
yt
ic
al
H
PL
C
206
Chromolith® HPLC columns